Roche last week said that it has received US Food and Drug Administration approval of a new pre-analytical instrument that integrates primary tube handling into its Cobas molecular testing platform.

The instrument, called the Cobas p 630, unites primary tube handling with fully automated sample preparation, nucleic acid amplification, and detection on the Cobas AmpliPrep or Cobas TaqMan analyzers, Roche said

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.